These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8529523)

  • 21. ATP gated potassium channels in acute myocardial hibernation and reperfusion.
    Offstad J; Kirkebøen KA; Ilebekk A; Downing SE
    Cardiovasc Res; 1994 Jun; 28(6):872-80. PubMed ID: 7923294
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of cromakalim or glibenclamide on arrhythmias and dispersion of refractoriness in chronically infarcted in anesthetized dogs.
    D'Alonzo AJ; Sewter JC; Darbenzio RB; Hess TA
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Aug; 352(2):222-8. PubMed ID: 7477447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selectivity of repaglinide and glibenclamide for the pancreatic over the cardiovascular K(ATP) channels.
    Stephan D; Winkler M; Kühner P; Russ U; Quast U
    Diabetologia; 2006 Sep; 49(9):2039-48. PubMed ID: 16865362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Defibrillatory action of glibenclamide is independent from ATP-sensitive K+ channels and free radicals.
    Csonka C; Onody A; Csont T; Ferdinandy P
    J Cardiovasc Pharmacol; 2003 Jun; 41(6):916-22. PubMed ID: 12775970
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blockade of vascular ATP-sensitive potassium channels reduces the vasodilator response to ischaemia in humans.
    Bijlstra PJ; den Arend JA; Lutterman JA; Russel FG; Thien T; Smits P
    Diabetologia; 1996 Dec; 39(12):1562-8. PubMed ID: 8960843
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological analysis in rat of the role of the ATP-sensitive potassium channel as a potential target for antifibrillatory intervention in acute myocardial ischaemia.
    Rees SA; Curtis MJ
    J Cardiovasc Pharmacol; 1995 Aug; 26(2):280-8. PubMed ID: 7475053
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Sulphonylurea derivatives and the cardiovascular system].
    Filipiak KJ
    Przegl Lek; 2000; 57 Suppl 4():19-22. PubMed ID: 11293225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monophosphoryl lipid A attenuates myocardial stunning in dogs: role of ATP-sensitive potassium channels.
    Elliott GT; Mei DA; Gross GJ
    J Cardiovasc Pharmacol; 1998 Jul; 32(1):49-56. PubMed ID: 9676720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of ATP-sensitive K+ channel blockers on the action potential shortening in hypoxic and ischaemic myocardium.
    Nakaya H; Takeda Y; Tohse N; Kanno M
    Br J Pharmacol; 1991 May; 103(1):1019-26. PubMed ID: 1908730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The molecular interaction of sulfonylureas with beta-cell ATP-sensitive K(+)-channels.
    Kramer W; Müller G; Girbig F; Gutjahr U; Kowalewski S; Hartz D; Summ HD
    Diabetes Res Clin Pract; 1995 Aug; 28 Suppl():S67-80. PubMed ID: 8529521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of ATP-sensitive K+ channel subtype selectivity of insulin secretagogues for the coronary vasculature and the myocardium.
    Quast U; Stephan D; Bieger S; Russ U
    Diabetes; 2004 Dec; 53 Suppl 3():S156-64. PubMed ID: 15561904
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glimepiride, a novel sulfonylurea, does not abolish myocardial protection afforded by either ischemic preconditioning or diazoxide.
    Mocanu MM; Maddock HL; Baxter GF; Lawrence CL; Standen NB; Yellon DM
    Circulation; 2001 Jun; 103(25):3111-6. PubMed ID: 11425777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glibenclamide effects on reperfusion-induced malignant arrhythmias and left ventricular mechanical recovery from stunning in conscious sheep.
    del Valle HF; Lascano EC; Negroni JA; Crottogini AJ
    Cardiovasc Res; 2001 Jun; 50(3):474-85. PubMed ID: 11376623
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glibenclamide attenuates the antiarrhythmic effect of endotoxin with a mechanism not involving K(ATP) channels.
    Iskit AB; Erkent U; Ertunc M; Guc MO; Ilhan M; Onur R
    Vascul Pharmacol; 2007 Feb; 46(2):129-36. PubMed ID: 17064967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of glibenclamide on ventricular arrhythmias and cardiac function in ischaemia and reperfusion in isolated rat heart.
    Bril A; Laville MP; Gout B
    Cardiovasc Res; 1992 Nov; 26(11):1069-76. PubMed ID: 1291084
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential interaction of glimepiride and glibenclamide with the beta-cell sulfonylurea receptor. I. Binding characteristics.
    Müller G; Hartz D; Pünter J; Okonomopulos R; Kramer W
    Biochim Biophys Acta; 1994 May; 1191(2):267-77. PubMed ID: 8172912
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular responses to glibenclamide during endotoxaemia in the pig.
    Vanelli G; Hussain SN; Dimori M; Aguggini G
    Vet Res Commun; 1997 Apr; 21(3):187-200. PubMed ID: 9090046
    [TBL] [Abstract][Full Text] [Related]  

  • 38. K(ATP) channel opening during ischemia: effects on myocardial noradrenaline release and ventricular arrhythmias.
    Remme CA; Schumacher CA; de Jong JW; Fiolet JW; de Groot JR; Coronel R; Wilde AA
    J Cardiovasc Pharmacol; 2001 Sep; 38(3):406-16. PubMed ID: 11486245
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protection from ischaemic-reperfusion injury with adenosine pretreatment is reversed by inhibition of ATP sensitive potassium channels.
    Toombs CF; McGee DS; Johnston WE; Vinten-Johansen J
    Cardiovasc Res; 1993 Apr; 27(4):623-9. PubMed ID: 8324796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of K(ATP)(+) channels and adenosine in the control of coronary blood flow during exercise.
    Richmond KN; Tune JD; Gorman MW; Feigl EO
    J Appl Physiol (1985); 2000 Aug; 89(2):529-36. PubMed ID: 10926635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.